Profile | GDS4284 / 206283_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 129.704 | 42 |
GSM687648 | Patient 402 control | 194.023 | 48 |
GSM687653 | Patient 403 control | 143.504 | 43 |
GSM687658 | Patient 404 control | 171.991 | 45 |
GSM687663 | Patient 411 control | 270.696 | 53 |
GSM687668 | Patient 422 control | 216.144 | 50 |
GSM687673 | Patient 424 control | 397.95 | 59 |
GSM687678 | Patient 425 control | 175.727 | 44 |
GSM687683 | Patient 427 control | 222.451 | 48 |
GSM687688 | Patient 428 control | 126.397 | 39 |
GSM687695 | Patient 441 control | 1441.29 | 81 |
GSM687699 | Patient 443 control | 306.97 | 54 |
GSM687704 | Patient 444 control | 214.125 | 50 |
GSM687707 | Patient 448 control | 197.398 | 44 |
GSM687712 | Patient 449 control | 200.843 | 48 |
GSM687719 | Patient 450 control | 345.071 | 56 |
GSM687724 | Patient 451 control | 266.001 | 52 |
GSM687728 | Patient 452 control | 330.22 | 57 |
GSM687646 | Patient 401 treated 24h | 94.2132 | 33 |
GSM687649 | Patient 402 treated 24h | 188.702 | 49 |
GSM687665 | Patient 411 treated 24h | 297.621 | 54 |
GSM687651 | Patient 402 treated 4 weeks | 175.693 | 45 |
GSM687667 | Patient 411 treated 4 weeks | 221.657 | 50 |
GSM687670 | Patient 422 treated 24h | 213.013 | 48 |
GSM687671 | Patient 422 treated 4 weeks | 171.236 | 46 |
GSM687654 | Patient 403 treated 24h | 111.125 | 39 |
GSM687675 | Patient 424 treated 24h | 317.712 | 55 |
GSM687685 | Patient 427 treated 24h | 278.06 | 54 |
GSM687656 | Patient 403 treated 4 weeks | 89.4376 | 35 |
GSM687677 | Patient 424 treated 4 weeks | 131.986 | 40 |
GSM687687 | Patient 427 treated 4 weeks | 174.682 | 47 |
GSM687692 | Patient 428 treated 4h | 114.353 | 37 |
GSM687716 | Patient 449 treated 4h | 146.476 | 43 |
GSM687722 | Patient 450 treated 4h | 192.846 | 44 |
GSM687680 | Patient 425 treated 24h | 98.5853 | 34 |
GSM687690 | Patient 428 treated 24h | 185.897 | 48 |
GSM687700 | Patient 443 treated 24h | 480.885 | 60 |
GSM687705 | Patient 444 treated 24h | 209.614 | 51 |
GSM687714 | Patient 449 treated 24h | 149.101 | 44 |
GSM687721 | Patient 450 treated 24h | 472.14 | 61 |
GSM687682 | Patient 425 treated 4 weeks | 241.046 | 53 |
GSM687694 | Patient 428 treated 4 weeks | 191.71 | 49 |
GSM687702 | Patient 443 treated 4 weeks | 139.767 | 39 |
GSM687718 | Patient 449 treated 4 weeks | 206.812 | 49 |
GSM687723 | Patient 450 treated 4 weeks | 244.872 | 51 |
GSM687661 | Patient 404 treated 4h | 194.054 | 47 |
GSM687710 | Patient 448 treated 4h | 442.84 | 62 |
GSM687726 | Patient 451 treated 4h | 429.283 | 60 |
GSM687730 | Patient 452 treated 4h | 1352.49 | 79 |
GSM687660 | Patient 404 treated 24h | 758.23 | 71 |
GSM687697 | Patient 441 treated 24h | 799.918 | 71 |
GSM687709 | Patient 448 treated 24h | 151.152 | 41 |
GSM687725 | Patient 451 treated 24h | 576.114 | 65 |
GSM687729 | Patient 452 treated 24h | 1009.54 | 76 |
GSM687727 | Patient 451 treated 4 weeks | 389.337 | 59 |
GSM687731 | Patient 452 treated 4 weeks | 358.295 | 57 |